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Abstract
Background Little information is available on ureteral or ves-
ical involvement in Henoch–Schönlein syndrome. To deter-
mine the features of this condition we performed a formal
analysis of peer-reviewed scientific literature on this topic.
Methods The US National Library of Medicine database was
used as the data source. All articles published as full-length
articles or letters were collected. Reports published in lan-
guages other than English, French, German, Italian or Spanish
were not considered.
Results We analyzed 32 reports describing 35 cases (24 male
and 11 female subjects aged between 3.5 and 63, median
7.0 years) with ureteral (n=30), vesical (n=4), or both ureteral
and vesical involvement (n=1). The presentation included col-
icky abdominal pain, macroscopic hematuria (sometimes con-
taining blood clots), urinary tract infection or urinary retention.
The diagnosis of ureteral involvement was often fortuitous.
Patients with vesical involvement weremanaged conservatively.
However, the majority of those with ureteral involvement were
managed surgically.
Conclusions Ureteral or vesical involvement is unusual and
likely underappreciated in Henoch–Schönlein syndrome.
Improved recognition and wider appreciation of this involve-
ment can help to avoid associated morbidity. Management
must be individualized for each patient. A multidisciplinary
approach may be of value in planning medical treatment,
surgical intervention, and follow-up.
Keywords Anaphylactoid purpura . Henoch–Schönlein
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Introduction
Henoch–Schönlein syndrome is the most common form of
childhood vasculitis with an estimated overall annual incidence
of 10–20 cases per 100,000 children under 17 years of age [1].
Palpable non-thrombocytopenic purpura concentrated on depen-
dent or pressure-bearing areas, arthralgia or arthritis, and abdom-
inal pain are the distinctive presentations of this condition [1].
Themost recognized genitourinarymanifestation of Henoch–
Schönlein syndrome is a kidney disease that affects 20–60 % of
cases and principally determines the long-term prognosis of
affected patients [1]. In addition, many boys develop scrotal
signs or symptoms secondary to edema and hematoma of the
scrotal wall or spermatic cord, testicular hemorrhage, subcapsu-
lar testicular hematoma, epididymitis or orchitis [1].
Ureteral or vesical involvement is uncommon. Since text-
books and recent reviews do not, or only marginally, mention
this rare complication of Henoch–Schönlein syndrome, we sys-
tematically reviewed and analyzed all the available literature.
Materials and methods
Between November 2012 and April 2013 we performed a
thorough computer-based search of the terms Henoch,
Schönlein, Henoch–Schönlein, Schönlein–Henoch, anaphy-
lactoid purpura, rheumatoid purpura, angiitis, vasculitis,
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hydronephrosis, ureter, ureteritis, and bladder in the US Na-
tional Library of Medicine database. We used the principles
established by the UK Economic and Social Research Council
guidance on the conduct of narrative synthesis and on the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses statement (Fig. 1). For the final analysis we
selected 32 reports available as a full-length article or as a
letter, which included cases of ureteral or vesical involvement
in Henoch–Schönlein syndrome published after 1960.
Henoch–Schönlein cases were classified as severe in the
presence of a kidney disease characterized by nephrotic range
proteinuria or in the presence of at least one of the following
infrequent complications: muscle involvement; protein-losing
enteropathy; pancreatitis; cholecystitis; intestinal infarction,
perforation or stricture; altered mental status; seizures; paresis;
blindness; peripheral neuropathy; pulmonary hemorrhage;
carditis; uveitis. The remaining cases were classified as mild.
The two-sided Mann–Whitney–Wilcoxon test for two inde-
pendent samples and the two-sided Fisher’s exact test were
performed for analysis. Significance was assumedwhen P<0.05.
Results
The literature retained for the final analysis included (Fig. 2) 35
Henoch–Schönlein cases (25 male and 10 female subjects) with
ureteral [2–30] (n=30), vesical [31–33] (n=4), or both ureteral
and vesical involvement [11] (n=1). The diagnosis of Henoch–
Schönlein syndrome was based on the classical palpable purpu-
ric rash in the presence of at least one of the following: diffuse
abdominal pain, arthritis or arthralgia, or a pathological urinaly-
sis [1]. Biopsy findings further supported the diagnosis of
Henoch–Schönlein syndrome in 13 cases: skin biopsy (n=3),
kidney biopsy (n=5) or both skin and kidney biopsy (n=5).
Ureteral or vesical involvement was recognized at between 1
week and 14 months, a median of 1 month after onset of
purpura. Henoch–Schönlein syndrome was mild in the 4 cases
with isolated vesical involvement (in these subjects imaging
studies excluded upper tract involvement) and severe in the case
with both ureteral and vesical involvement. In the 30 patients
with isolated ureteral involvement the syndrome was severe in
11 and mild in the remaining 19 cases.
Ureteral involvement
The 31 Henoch–Schönlein patients with ureteral involvement
consisted of 23 male and 8 female subjects aged between 3.5
and 63 years (Fig. 2). Diagnostic imaging studies disclosing
the ureteral involvement were performed in 9 patients with
both colicky abdominal pain and macroscopic hematuria, in 8
with colicky abdominal pain, in 4 with macroscopic hematuria
(but without concurrent abdominal pain), and in 2 with a
urinary tract infection. The diagnosis of ureteral involvement
was fortuitous in the remaining patients (diagnostic imaging
performed for other reasons, e.g., before kidney biopsy).
Microscopic hematuria had been noted in the patients without
macroscopic hematuria or urinary tract infection.
Forty-six of the 62 ureteral units were obstructed in the 31
patients: the obstruction was unilateral in 16 and bilateral in 15
patients (Table 1). The obstruction mostly affected the proxi-
mal ureter. A 21-year old patient [24] initially presented with a
proximal obstruction of the left ureter that was followed by an
ipsilateral distal obstruction 4 weeks later. Twenty-eight ure-
ters were partially and the remaining 19 were completely
obstructed (Table 2). The management was expectative, med-
ical with corticosteroid, surgical, or both medical and surgical.
Ninety-five percent of the cases with complete obstruction
required a surgical approach (with or without corticosteroids).
Records identified through search in in the U.S. National Library of 
Medicine database  (N = 133) 
Records searched after duplicates removed (n = 80)  
Records excluded after abstract and title review (n = 35)  
Citations assessed in detail for eligibility (n = 45)  
Articles not pertaining (n = 16)  
Eligible reports (n = 32)  
Reports found in reference lists (n = 3)  
Fig. 1 Flowchart of the literature
search process. The case of an
Italian boy reported twice [3, 18]
in the literature was considered
only once
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However, the majority of the cases (54 %) with partial ob-
struction were managed expectantly or medically.
The course was spontaneously favorable in 3 out of 6
partially obstructed ureters (50 %; including a boy with ure-
teral rupture [10]). Twenty-one ureters were treated with cor-
ticosteroids: the course was favorable in 10 and unfavorable in
the remaining 11 ureters. Three initially expectantly managed
ureters, 11 initially with corticosteroid managed ureters, and
the remaining 17 ureters were approached surgically (with or
without concurrent drug management with corticosteroids).
The surgical approach, which was mostly preceded by a
pyelostomy, included: (1) Nephrectomy in 2 patients with
unilateral proximal obstruction and very poor ipsilateral kid-
ney function; (2) Insertion of a stent into the obstructed ureter
in 2 cases; (3) Ileal ureteral replacement in 12 cases; (4)
Pyeloplasty in the remaining ureters.
Stent insertion, ureteral replacement, and pyeloplasty were
reported to be successful in all cases.
The course was similar in 19 patients with mild (surgery
required in 19 ureters) and in 11 with severe (surgery required
in 12 ureters) Henoch–Schönlein syndrome.
Ureteral specimens, examined histologically in 10
cases, disclosed fibrosis and chronic inflammation. Char-
acteristic vasculitic findings were noted in 5 cases (a
direct immunofluorescence study, performed in 2 chil-
dren, disclosed depositions of immunoglobulin A).
Vesical involvement
The 5 patients with vesical involvement presented with gross
hematuria. Acute urinary retention and a urinary tract infection
were also noted in one case. Diagnostic imaging, sometimes
associated with a cystoscopy, disclosed diffuse mucosal thick-
ening of the bladder. In one case a blood clot obstructing the
bladder outlet and a large intramural hematoma were also
noted. The management was expectative (without corticoste-
roids). A bladder catheter was inserted in the patient with
urinary retention secondary to a large blood clot [32]. A biopsy
of the bladder mucosa to support the diagnosis was never
performed.
Discussion
The long-term prognosis of Henoch–Schönlein syndrome is
nearly totally attributable to kidney disease [1]. The present
review complements the results of a preliminary review of the
literature published 5 years ago [26]. It confirms that ureteral
or vesical involvement, whose occurrence has never been
analyzed quantitatively, is very rare, but, if present, is associ-
ated with substantial morbidity. Furthermore, the review sub-
stantiates the belief that ureteral or vesical involvement is the
consequence of vasculitic lesions. Finally, the analysis sug-
gests that Henoch–Schönlein syndrome with ureteral or ves-
ical involvement, like the classical form of Henoch–Schönlein
syndrome, might be found in all age groups, but occurs most
often between the ages of 5 and 9 years with a male to female
ratio of approximately 2:1 [1]. The discussion focuses on the
presentation and the management of Henoch–Schönlein syn-
drome with ureteral involvement.
In Henoch–Schönlein syndrome, ureteritis, like in other
systemic vasculitides, characteristically causes luminal obliter-
ation (owing to wall inflammation or to bleeding with clot
formation) or, more rarely, ureteral rupture [34–36]. Henoch–
Schönlein ureteritis is likely underappreciated (and its diagnosis
delayed) because it occurs rarely and, more importantly,
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Fig. 2 Age distribution in 35 Henoch–Schönlein patients (24 male and
11 female subjects) with ureteral or vesical involvement
Table 1 Ureteral obstruction in 31 patients (23 male and 8 female
subjects) affected by Henoch–Schönlein syndrome. The ureteral obstruc-
tion was unilateral in 16 and bilateral in 15 patients. The difference
between male and female subjects was not significant
Right ureter (n) Left ureter (n)
All Female Male All Female Male
Proximal 14 4 10 19 4 15
Middle 2 1 1 3 1 2
Distal 5 2 3 4a 1 3
a Late obstruction of the left distal ureter developed in a 21-year-old man
initially presenting with obstruction of the ipsilateral proximal ureter [24]
Table 2 Initial therapeutic intervention in Henoch–Schönlein patients
with partial or complete ureteral obstruction
Partial obstruction
(n =28)
Complete obstruction
(n =19)
Expectative 6 0
Corticosteroids alone 9 1
Surgery alone 7 10
Corticosteroids and surgery 6 8
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because its clinical symptoms, namely colicky abdominal pain
and gross hematuria, are mostly attributed to intestinal or renal
disease. On the other hand, some reported cases of proximal
ureteral obstructionmight actually be a congenital ureteropelvic
junction obstruction that is unrelated to this vasculitis syn-
drome. Although in Henoch–Schönlein patients abdominal
pain is almost always caused by submucosal or subserosal
bleeding and swelling within the intestine, abdominal ultra-
sound examination is currently often performed to exclude
intussusception [1]. Combining abdominal with renal tract
ultrasound is a rather simple and non-invasive tool that would
likely prevent a delayed diagnosis of ureteral obstruction. This
diagnostic technique appears warranted at least in patients with
abdominal pain and hematuria. The diagnosis of ureteral steno-
sis, which is suspected on ultrasound, currently deserves con-
firmation either by scintigraphy or by magnetic resonance
urography. Compared with scintigraphy, magnetic resonance
urography could have the potential to provide equivalent infor-
mation about renal function, but superior information regarding
morphology [37].
Controlled trials are not realistic with rare and heteroge-
neous conditions such as ureteral and vesical involvement in
Henoch–Schönlein syndrome. With these limitations in mind,
the data of the present analysis prompt us to shortly address
both medical and surgical management of ureteral involve-
ment. Corticosteroids in the acute phase of Henoch–Schönlein
syndrome do alleviate and treat extra-renal symptoms [38,
39], but these studies, like the present review, do not give data
on their efficacy on ureteral (or vesical) involvement. Contro-
versy has remained as to whether corticosteroids can prevent
the development of kidney disease and reduce its severity
[40], but recent data suggest that early corticosteroid treatment
does not prevent kidney disease [41, 42]. Since stenosing
ureteritis is self-limited in some instances (and occasionally
[43] ameliorates on corticosteroids), surgery other than
pyelostomy deserves consideration in patients with persisting
ureteral stenosis or a rather low disease activity. Traditional
operative reconstruction has been mostly used. Balloon dila-
tation or stenting, which have been recently used in kidney
transplant recipients affected by ureteral stenosis, may be a
further option [44, 45].
Conclusions
This review confirms that ureteral or vesical involvement is
very unusual and likely underappreciated in Henoch–
Schönlein syndrome. Improved recognition and wider appre-
ciation of ureteral and vesical involvement could help avoid
the substantial associated morbidity. The management must
be individualized for each patient. A multidisciplinary ap-
proach may be of value in planning medical treatment, surgi-
cal intervention, and follow-up.
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